Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion

1 month ago 19
The acquisition brings a caller attack to treating allergic diseases to the company’s immunology pipeline.
Read Entire Article
  1. Homepage
  2. Technology
  3. Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion

Related

What to Stream: 'Wuthering Heights,' Kacey Musgraves, Tori Amos and a double dose of Matthew Rhys

What to Stream: 'Wuthering Heights,' Kacey Musgraves, Tori A...

2 hours ago 0
Elon Musk Is an Underdog in His $180 Billion Fight Against OpenAI

Elon Musk Is an Underdog in His $180 Billion Fight Against O...

6 hours ago 0
The threat of light pollution puts the world’s darkest skies in the Atacama Desert at risk

The threat of light pollution puts the world’s darkest skies...

7 hours ago 0

Popular

7 New Songs You Should Hear Now

7 New Songs You Should Hear Now

5 days ago 31
Vance’s Trip to Islamabad on Hold as U.S. Says Iran Failed to Respond to Its Terms

Vance’s Trip to Islamabad on Hold as U.S. Says Iran Failed t...

5 days ago 31
Pentagon to Stop Requiring Members of Military to Get Flu Vaccines

Pentagon to Stop Requiring Members of Military to Get Flu Va...

5 days ago 23
Areas getting 'beaver ready' for possible release

Areas getting 'beaver ready' for possible release

5 days ago 21
The Trump administration announced criminal charges, sanctions and multimillion-dollar rewards aimed at combating online scams coming out of Southeast Asia and targeting Americans

The Trump administration announced criminal charges, sanctio...

3 days ago 18
About Us · Contact Us · Privacy Policy ·

© DISQUS CLUB 2026. All rights are reserved